Literature DB >> 19822900

Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.

Jonathan A Gutman1, Cameron J Turtle, Thomas J Manley, Shelly Heimfeld, Irwin D Bernstein, Stanley R Riddell, Colleen Delaney.   

Abstract

We investigated the potential role of an immune reaction in mediating the dominant engraftment of 1 cord blood unit in 14 patients who received a double-unit cord blood transplantation (CBT). In 10 patients, dominant engraftment of a single donor unit emerged by day 28 after CBT. In 9 of these 10 patients, a significant subset of CD8(+) CD45RO(+/-)CCR7(-) T cells, present in peripheral blood mononuclear cells and derived from the engrafting cord blood unit, produced interferon-gamma (IFN-gamma) in response to the nonengrafting unit. No significant population of IFN-gamma-secreting cells was detectable when posttransplantation peripheral blood mononuclear cells were stimulated against cells from the engrafted unit (P < .001) or from a random human leukocyte antigen disparate third party (P = .003). Three patients maintained persistent mixed chimerism after CBT, and no significant IFN-gamma-secreting cells were detected after similar stimulations in these patients (P < .005). Our data provide the first direct evidence in human double-unit CBT recipients that immune rejection mediated by effector CD8(+) T cells developing after CBT from naive precursors is responsible for the failure of 1 unit to engraft. Future investigations based on these findings may result in strategies to predict a dominant unit and enhance graft-versus-leukemia effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822900      PMCID: PMC2815516          DOI: 10.1182/blood-2009-07-228999

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44.

Authors:  K Fleischhauer; N A Kernan; R J O'Reilly; B Dupont; S Y Yang
Journal:  N Engl J Med       Date:  1990-12-27       Impact factor: 91.245

Review 2.  CD8 T cell memory.

Authors:  B Rocha; C Tanchot
Journal:  Semin Immunol       Date:  2004-10       Impact factor: 11.130

3.  Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.

Authors:  G D'Arena; P Musto; N Cascavilla; G Di Giorgio; S Fusilli; F Zendoli; M Carotenuto
Journal:  Haematologica       Date:  1998-03       Impact factor: 9.941

4.  Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for acute leukemia in complete remission: a matched cohort analysis.

Authors:  Jonathan A Gutman; Wendy Leisenring; Frederick R Appelbaum; Ann E Woolfrey; Colleen Delaney
Journal:  Biol Blood Marrow Transplant       Date:  2009-09       Impact factor: 5.742

5.  Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.

Authors:  Mary J Laughlin; Mary Eapen; Pablo Rubinstein; John E Wagner; Mei-Jei Zhang; Richard E Champlin; Cladd Stevens; Juliet N Barker; Robert P Gale; Hillard M Lazarus; David I Marks; Jon J van Rood; Andromachi Scaradavou; Mary M Horowitz
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

6.  Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.

Authors:  P Rubinstein; L Dobrila; R E Rosenfield; J W Adamson; G Migliaccio; A R Migliaccio; P E Taylor; C E Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

7.  Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors.

Authors:  Margaret L MacMillan; Daniel J Weisdorf; Claudio G Brunstein; Qing Cao; Todd E DeFor; Michael R Verneris; Bruce R Blazar; John E Wagner
Journal:  Blood       Date:  2008-11-07       Impact factor: 22.113

8.  Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero.

Authors:  Jeff E Mold; Jakob Michaëlsson; Trevor D Burt; Marcus O Muench; Karen P Beckerman; Michael P Busch; Tzong-Hae Lee; Douglas F Nixon; Joseph M McCune
Journal:  Science       Date:  2008-12-05       Impact factor: 47.728

9.  T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A.

Authors:  A B Rickinson; M Rowe; I J Hart; Q Y Yao; L E Henderson; H Rabin; M A Epstein
Journal:  Cell Immunol       Date:  1984-09       Impact factor: 4.868

10.  Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.

Authors:  Celso A Rodrigues; Guillermo Sanz; Claudio G Brunstein; Jaime Sanz; John E Wagner; Marc Renaud; Marcos de Lima; Mitchell S Cairo; Sabine Fürst; Bernard Rio; Christopher Dalley; Enric Carreras; Jean-Luc Harousseau; Mohamad Mohty; Denis Taveira; Peter Dreger; Anna Sureda; Eliane Gluckman; Vanderson Rocha
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

View more
  59 in total

1.  Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.

Authors:  Junya Kanda; David A Rizzieri; Cristina Gasparetto; Gwynn D Long; John P Chute; Keith M Sullivan; Ashley Morris; Clayton A Smith; Donna E Hogge; Janet Nitta; Kevin Song; Donna Niedzwiecki; Nelson J Chao; Mitchell E Horwitz
Journal:  Biol Blood Marrow Transplant       Date:  2010-09-22       Impact factor: 5.742

2.  Effect of parity on fetal and maternal microchimerism: interaction of grafts within a host?

Authors:  Hilary S Gammill; Katherine A Guthrie; Tessa M Aydelotte; Kristina M Adams Waldorf; J Lee Nelson
Journal:  Blood       Date:  2010-07-13       Impact factor: 22.113

3.  Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaques.

Authors:  S K Ramakrishnan; A Page; A B Farris; K Singh; F Leopardi; K Hamby; S Sen; A Polnett; T Deane; M Song; L Stempora; E Strobert; A D Kirk; C P Larsen; L S Kean
Journal:  Am J Transplant       Date:  2012-05-29       Impact factor: 8.086

4.  Natural killer cell licensing after double cord blood transplantation is driven by the self-HLA class I molecules from the dominant cord blood.

Authors:  Nicolas Guillaume; Pascale Loiseau; Katia Gagne; Hélène Moins Teissserenc; Jean-Michel Cayuela; Guylaine Henry; Marie Robin; Régis Peffault de Latour; Eliane Gluckman; Gérard Socié; Christelle Retiere; Nicolas Dulphy; Antoine Toubert
Journal:  Haematologica       Date:  2016-01-27       Impact factor: 9.941

Review 5.  Alternative donor transplantation--"mixing and matching": the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors?

Authors:  Hongtao Liu; Koen van Besien
Journal:  Curr Hematol Malig Rep       Date:  2015-03       Impact factor: 3.952

6.  HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection.

Authors:  Cladd E Stevens; Carmelita Carrier; Carol Carpenter; Dorothy Sung; Andromachi Scaradavou
Journal:  Blood       Date:  2011-07-12       Impact factor: 22.113

7.  Cognate HLA absence in trans diminishes human NK cell education.

Authors:  Vanessa Landtwing; Ana Raykova; Gaetana Pezzino; Vivien Béziat; Emanuela Marcenaro; Claudine Graf; Alessandro Moretta; Riccarda Capaul; Andrea Zbinden; Guido Ferlazzo; Karl-Johan Malmberg; Obinna Chijioke; Christian Münz
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

8.  Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia.

Authors:  Andromachi Scaradavou; Claudio G Brunstein; Mary Eapen; Jennifer Le-Rademacher; Juliet N Barker; Nelson Chao; Corey Cutler; Colleen Delaney; Fangyu Kan; Luis Isola; Chatchada Karanes; Mary J Laughlin; John E Wagner; Elizabeth J Shpall
Journal:  Blood       Date:  2012-12-09       Impact factor: 22.113

9.  Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.

Authors:  Colleen Delaney; Shelly Heimfeld; Carolyn Brashem-Stein; Howard Voorhies; Ronald L Manger; Irwin D Bernstein
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

10.  Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodies.

Authors:  Parastoo B Dahi; Jonathan Barone; Sean M Devlin; Courtney Byam; Marissa Lubin; Doris M Ponce; Sergio Giralt; Nancy A Kernan; Andromachi Scaradavou; Susan H Hsu; Juliet N Barker
Journal:  Biol Blood Marrow Transplant       Date:  2014-01-23       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.